MSD Global Health Innovation Fund

← Back to your selection

Activity in this selectionOct 7, 2026 · Jan 1, 2026

Rounds participated in: 2
Confirmed lead rounds: 0
New companies: 2
Funding in participating rounds: $59.4M

By stage

Series A1

Series B1

By primary sector

Biotech1

Enterprise software1

By country

France1

Hungary1

Rounds

2 in this selection

Sep 22

Biolevate

Biolevate automates evidence-based operational workflows for regulated life-sciences companies, helping enterprise teams organize and execute complex processes.

€30MSeries A

Participant

Feb 24

Turbine

Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation

$25MSeries B

Role not disclosed